The intricate process of drug development relies heavily on the availability of sophisticated chemical intermediates. For research and development scientists, compounds that offer precise stereochemistry and versatility in synthesis are invaluable. (1S,2R)-2-(benzylamino)-1,2-diphenylethanol, known by its CAS number 153322-12-4, stands out as a significant chiral building block in this domain.

As an R&D scientist, your primary goal is to synthesize novel compounds with therapeutic potential. Integrating intermediates like (1S,2R)-2-(benzylamino)-1,2-diphenylethanol into your synthesis strategies allows for the construction of complex molecular structures crucial for drug discovery. When considering where to buy this compound, prioritizing suppliers who can provide high-purity material is essential. Exploring options from established chemical manufacturers, particularly those in China, can offer competitive pricing and reliable supply chains.

The price of CAS 153322-12-4 can vary, and it is advisable for procurement specialists to obtain multiple quotes to ensure cost-effectiveness for research projects or pilot-scale production. Understanding the chemical properties and potential applications of this intermediate is key to its efficient utilization. Its role as a chiral synthon means it is often employed in asymmetric synthesis to create enantiomerically pure drug candidates.

For those in medicinal chemistry, the exploration of new therapeutic agents often involves modifying known scaffolds or building entirely new ones. (1S,2R)-2-(benzylamino)-1,2-diphenylethanol offers a unique structural motif that can be explored for its potential interactions with biological targets. Identifying a reliable (1S,2R)-2-(benzylamino)-1,2-diphenylethanol supplier in China can facilitate consistent access to this important intermediate, supporting the iterative process of drug design and optimization.

Ultimately, the successful incorporation of intermediates like CAS 153322-12-4 into drug development pipelines depends on the quality, availability, and cost-effectiveness of the supply chain. By partnering with knowledgeable chemical manufacturers, R&D teams can accelerate their discovery efforts and bring promising new therapies closer to reality.